Literature DB >> 17064670

Neural differentiation potential of peripheral blood- and bone-marrow-derived precursor cells.

Sangnyon Kim1, Osamu Honmou, Kazunori Kato, Tadashi Nonaka, Kiyohiro Houkin, Hirufumi Hamada, Jeffery D Kocsis.   

Abstract

Transplantation of mesenchymal stem cells (MSCs) prepared from adult bone marrow (BMSCs) has been reported to ameliorate functional deficits in several CNS diseases in experimental animal models. Bone marrow was enriched in MSCs by selecting for plastic-adherent cells that were grown to confluency in appropriate culture conditions as flattened fibroblast-like cells. Despite the fact that the stem/precursor cells in peripheral blood are widely used for reconstruction in the hematopoietic system, it is not fully understood whether peripheral blood-derived plastic-adherent precursor/stem cells (PMSCs) can differentiate into a neural lineage. To compare the potential of PMSCs and BMSCs for neural differentiation in vitro, BMSCs and PMSCs were prepared from the adult rat and expanded in culture. Although the growth rate of PMSCs was less than BMSCs, immunocytochemical and RT-PCR analyses indicated that both MSC types were successfully induced to nestin-positive neurospheres in the presence of EGF and bFGF. After withdrawal of the mitogens, these cells could differentiate into neurofilament-positive neurons or GFAP-positive glia. Thus, our findings suggest the potential use of PMSCs for a cell therapy in CNS diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17064670      PMCID: PMC2605382          DOI: 10.1016/j.brainres.2006.09.044

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  20 in total

1.  Evidence of peripheral blood-derived, plastic-adherent CD34(-/low) hematopoietic stem cell clones with mesenchymal stem cell characteristics.

Authors:  R Huss; C Lange; E M Weissinger; H J Kolb; K Thalmeier
Journal:  Stem Cells       Date:  2000       Impact factor: 6.277

Review 2.  Precursor cells of mechanocytes.

Authors:  A J Friedenstein
Journal:  Int Rev Cytol       Date:  1976

3.  Telomerized human multipotent mesenchymal cells can differentiate into hematopoietic and cobblestone area-supporting cells.

Authors:  Masayoshi Kobune; Yutaka Kawano; Yoshinori Ito; Hiroki Chiba; Kiminori Nakamura; Hajime Tsuda; Katsunori Sasaki; Hironari Dehari; Hiroaki Uchida; Osamu Honmou; Sho Takahashi; Akiko Bizen; Rishu Takimoto; Takuya Matsunaga; Junji Kato; Kazunori Kato; Kiyohiro Houkin; Yoshiro Niitsu; Hirofumi Hamada
Journal:  Exp Hematol       Date:  2003-08       Impact factor: 3.084

4.  Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy.

Authors:  O N Koç; S L Gerson; B W Cooper; S M Dyhouse; S E Haynesworth; A I Caplan; H M Lazarus
Journal:  J Clin Oncol       Date:  2000-01       Impact factor: 44.544

Review 5.  Marrow stromal cells as stem cells for nonhematopoietic tissues.

Authors:  D J Prockop
Journal:  Science       Date:  1997-04-04       Impact factor: 47.728

6.  Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry.

Authors:  J G Bender; K L Unverzagt; D E Walker; W Lee; D E Van Epps; D H Smith; C C Stewart; L B To
Journal:  Blood       Date:  1991-06-15       Impact factor: 22.113

7.  Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart.

Authors:  Catalin Toma; Mark F Pittenger; Kevin S Cahill; Barry J Byrne; Paul D Kessler
Journal:  Circulation       Date:  2002-01-01       Impact factor: 29.690

8.  Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH).

Authors:  O N Koç; J Day; M Nieder; S L Gerson; H M Lazarus; W Krivit
Journal:  Bone Marrow Transplant       Date:  2002-08       Impact factor: 5.483

9.  A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats.

Authors:  Satoshi Iihoshi; Osamu Honmou; Kiyohiro Houkin; Kazuo Hashi; Jeffery D Kocsis
Journal:  Brain Res       Date:  2004-05-08       Impact factor: 3.252

10.  Mesenchymal precursor cells in the blood of normal individuals.

Authors:  N J Zvaifler; L Marinova-Mutafchieva; G Adams; C J Edwards; J Moss; J A Burger; R N Maini
Journal:  Arthritis Res       Date:  2000-08-31
View more
  30 in total

Review 1.  Migration and fate of therapeutic stem cells in different brain disease models.

Authors:  B J Carney; K Shah
Journal:  Neuroscience       Date:  2011-09-14       Impact factor: 3.590

Review 2.  Genetic engineering of mesenchymal stem cells and its application in human disease therapy.

Authors:  Conrad P Hodgkinson; José A Gomez; Maria Mirotsou; Victor J Dzau
Journal:  Hum Gene Ther       Date:  2010-10-22       Impact factor: 5.695

3.  Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke.

Authors:  Osamu Honmou; Kiyohiro Houkin; Takuya Matsunaga; Yoshiro Niitsu; Sumio Ishiai; Rie Onodera; Stephen G Waxman; Jeffery D Kocsis
Journal:  Brain       Date:  2011-04-14       Impact factor: 13.501

Review 4.  Stem Cells Transplantation and Huntington's Disease.

Authors:  Wooseok Im; Soon-Tae Lee; Kon Chu; Manho Kim; Jae-Kyu Roh
Journal:  Int J Stem Cells       Date:  2009-05       Impact factor: 2.500

5.  Stem Cell Research and Health Education.

Authors:  David J Eve; Phillip J Marty; Robert J McDermott; Stephen K Klasko; Paul R Sanberg
Journal:  Am J Health Educ       Date:  2008

6.  Characteristics of Mesenchymal Stem Cells - New Stars in Regenerative Medicine or Unrecognized Old Fellows in Autologous Regeneration?

Authors:  Richard Schäfer; Hinnak Northoff
Journal:  Transfus Med Hemother       Date:  2008-05-21       Impact factor: 3.747

7.  Mechanotransduction Effects on Endothelial Cell Proliferation via CD31 and VEGFR2: Implications for Immunomagnetic Separation.

Authors:  Kalpesh D Mahajan; Gauri M Nabar; Wei Xue; Mirela Anghelina; Nicanor I Moldovan; Jeffrey J Chalmers; Jessica O Winter
Journal:  Biotechnol J       Date:  2017-08-14       Impact factor: 4.677

8.  A simple method to generate adipose stem cell-derived neurons for screening purposes.

Authors:  Caterina Bossio; Rosa Mastrangelo; Raffaella Morini; Noemi Tonna; Silvia Coco; Claudia Verderio; Michela Matteoli; Fabio Bianco
Journal:  J Mol Neurosci       Date:  2013-03-07       Impact factor: 3.444

9.  Intravenous Infusion of Mesenchymal Stem Cells Alters Motor Cortex Gene Expression in a Rat Model of Acute Spinal Cord Injury.

Authors:  Tsutomu Oshigiri; Toru Sasaki; Masanori Sasaki; Yuko Kataoka-Sasaki; Masahito Nakazaki; Shinichi Oka; Tomonori Morita; Ryosuke Hirota; Mitsunori Yoshimoto; Toshihiko Yamashita; Kazue Hashimoto-Torii; Osamu Honmou
Journal:  J Neurotrauma       Date:  2018-08-10       Impact factor: 5.269

10.  Isolation and characterization of novel, highly proliferative human CD34/CD73-double-positive testis-derived stem cells for cell therapy.

Authors:  Won Yun Choi; Hwang Gyun Jeon; Young Chung; Jung Jin Lim; Dong Hyuk Shin; Jung Mo Kim; Byeong Seong Ki; Seung-Hun Song; Seong-Jun Choi; Keun-Hong Park; Sung Han Shim; Jisook Moon; Sung Jun Jung; Hyun Mi Kang; Seah Park; Hyung Min Chung; Jung Jae Ko; Kwang Yul Cha; Tae Ki Yoon; Haekwon Kim; Dong Ryul Lee
Journal:  Stem Cells Dev       Date:  2013-05-03       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.